Tag: Advicenne
Advicenne: ADV7103 designated orphan drug in the United States – 03/25/2024 at 09:59
(AOF) – Advicenne announces that its drug ADV7103 has obtained orphan drug designation (ODD) from the FDA for the treatment of cystinuria in the United States. The biotech specializing in…
Advicenne: ODD designation in cystinuria
(CercleFinance.com) – The biopharmaceutical company Advicenne announces that ADV7103, its proprietary drug, has obtained orphan drug status (ODD) from the US FDA for the treatment of cystinuria in the United…
Advicenne: the title sanctioned after the 2023 sales – 01/24/2024 at 12:30 p.m.
(CercleFinance.com) – The pharmaceutical company Advicenne was sanctioned on the stock market this Wednesday after reporting a slowdown in the growth of sales of Sibnayal, its main product. On the…
Advicenne: the title sanctioned after the 2023 sales
(CercleFinance.com) – The pharmaceutical company Advicenne was sanctioned on the stock market this Wednesday after reporting a slowdown in the growth of sales of Sibnayal, its main product. On the…
Advicenne grows by 20% in 2023, Sibnayal in the spotlight
(AOF) – Advicenne announced that its gross sales reached 4.4 million euros in 2023, up 20% year-on-year. This biotech specialist in innovative treatments against rare kidney diseases specifies that this…
Advicenne grows by 20% in 2023, Sibnayal in the spotlight – 01/23/2024 at 6:27 p.m.
(AOF) – Advicenne announced that its gross sales reached 4.4 million euros in 2023, up 20% year-on-year. This biotech specialist in innovative treatments against rare kidney diseases specifies that this…
Advicenne: the CDC less than 25% of the votes
(CercleFinance.com) – The Caisse des Dépôts et Consignations (CDC) declared to the AMF that it had crossed downward on October 4 through Bpifrance Investissement, which acts on behalf of the…
Advicenne announces the results of its capital increase with maintenance of preferential subscription rights
(Boursier.com) — Advicenne announces the results of the capital increase through the issue of new ordinary shares with maintenance of shareholders’ preferential subscription rights announced on September 11, 2023. This…
Advicenne reduces its half-year losses and launches a capital increase – 09/11/2023 at 6:10 p.m.
(AOF) – “As of June 30, 2023, Advicenne has a cash position of 3.42 million euros. As of September 11, the company has financial visibility “until the first quarter of…
Advicenne: launch of a capital increase – 09/11/2023 at 6:27 p.m.
(CercleFinance.com) – Advicenne announces the launch of a capital increase by issuing new ordinary shares (the “New Shares”) with maintenance of shareholders’ preferential subscription rights (the “DPS”) of an initial…
Advicenne reduces its half-year losses and launches a capital increase
(AOF) – “As of June 30, 2023, Advicenne has a cash position of 3.42 million euros. As of September 11, the company has financial visibility “until the first quarter of…
Advicenne: launch of a capital increase
(CercleFinance.com) – Advicenne announces the launch of a capital increase by issuing new ordinary shares (the “New Shares”) with maintenance of shareholders’ preferential subscription rights (the “DPS”) of an initial…